MRIs in the future could be safer thanks to the granting of a US patent for radiology software which reduces the amount of contrast agent, gadolinium, needed by 90%. The software uses artificial...
A new tool to help multiple sclerosis (MS) patients choose the best treatment for them. There are currently 18 approved disease-modifying therapies available on the NHS in the UK, and a group of...
People with multiple sclerosis (MS) who experience restless leg syndrome are more likely to have greater disability and MRI lesions than those who do not, a new study has found.
The study’s...
Mindfulness can reduce depression in people with multiple sclerosis (MS), a new study has found.
The research, which took place in an outpatient clinic in Germany, found that reducing depression also...
The majority of people with multiple sclerosis (MS) who catch Covid-19 go on to experience worsening of current symptoms, or new symptoms, a new survey has found.
The UK MS Register Covid-19 study...
A new study has found that high blood levels of the proteins neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) can indicate an increased risk of worsening disability in...
Over a third of people living with multiple sclerosis (MS) have hidden their condition from others, a new survey has found.
Out of the 800 people with MS asked, one in 10 people admitted they had...
The National Institute for Health and Care Excellence (NICE) has recommended Kesimpta (ofatumumab), which is a new treatment for people with multiple sclerosis (MS), to be prescribed on the NHS in...
Multiple sclerosis (MS) prevalence rises with countries’ prosperity, according to a new study, and occurs more in developed countries.
Researchers used data from 195 countries that was collected in...
Tysabri (natalizumab) significantly reduces disease activity and the number of relapses in people with paediatric-onset multiple sclerosis (POMS), new real-world study from Portugal has found....
